Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lun Jie Li"'
Publikováno v:
Clinical Pharmacology & Therapeutics. 110:464-472
This study assessed the effects of dipeptidyl peptidase-4 inhibitors (DPP4is) vs. sulfonylureas (SUs) on composite renal, cardiovascular, and hospitalized hypoglycemia outcomes in type 2 diabetes (T2D) patients with advanced chronic kidney disease (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45943f4105cbc570f6354627249f8a4
https://doi.org/10.1002/cpt.2262
https://doi.org/10.1002/cpt.2262
Publikováno v:
2021 IEEE 20th International Conference on Trust, Security and Privacy in Computing and Communications (TrustCom).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8eede3ffda0a504639b32f43b5f4457e
https://doi.org/10.1109/trustcom53373.2021.00136
https://doi.org/10.1109/trustcom53373.2021.00136
Autor:
Huang Tz Ou, Pei Fang Su, Shihchen Kuo, Chen Yi Yang, Wei Ann Lin, Lun Jie Li, Chun Ting Yang
Publikováno v:
Clinical pharmacology and therapeutics. 109(3)
This study explored heterogeneous treatment effects (HTEs) of the real-world use of dipeptidyl peptidase-4 inhibitors (DPP-4is) vs. sulfonylureas (SUs) on cardiovascular diseases (CVDs) and mortality in patients with type 2 diabetes. Utilizing Taiwan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab13dc5f5fc5633db811cecdcd6e94c7
https://pubmed.ncbi.nlm.nih.gov/32978779
https://pubmed.ncbi.nlm.nih.gov/32978779